CD8A and neoplasm: Other potential biomarkers include microsatellite instability (MSI) [121–123], mismatch repair deficiency (dMMR) [124–126], a 4-gene inflammatory signature score [127], and the level of infiltration of CD8+ T cells or TIL within the tumor [51].